Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone

被引:13
|
作者
Moes, Arthur D. [1 ]
Severs, David [1 ]
Verdonk, Koen [2 ]
van der Lubbe, Nils [1 ]
Zietse, Robert [1 ]
Danser, A. H. J. [2 ]
Hoorn, Ewout J. [1 ]
机构
[1] Erasmus Univ, Erasmus Med Ctr, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands
[2] Erasmus Univ, Erasmus Med Ctr, Dept Internal Med, Div Pharmacol & Vasc Med, Rotterdam, Netherlands
来源
FRONTIERS IN PHYSIOLOGY | 2018年 / 9卷
关键词
angiotensin II; endothelin-1; salt-sensitive hypertension; sodium transporters; wire myographs; II TYPE-2 RECEPTOR; SODIUM-CHLORIDE COTRANSPORTER; IMMUNE CELL INFILTRATION; NA-CL COTRANSPORTER; ANGIOTENSIN-II; BLOOD-PRESSURE; SENSITIVE HYPERTENSION; MEDIATED VASODILATION; ACTIVATION; VASOCONSTRICTION;
D O I
10.3389/fphys.2018.00578
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Inflammation is increasingly recognized as a driver of hypertension. Both genetic and pharmacological inhibition of B and T cells attenuates most forms of experimental hypertension. Accordingly, the immunosuppressive drug mycophenolate mofetil (MMF) reduces blood pressure in the deoxycorticosterone acetate (DOCA-) salt model. However, the mechanisms by which MMF prevent hypertension in the DOCA-salt model remain unclear. Recent studies indicate that immunosuppression can inhibit sodium transporter activity in the kidney, but its effect on vascular tone is not well characterized. Therefore, the aim of the present study was to analyze the vascular and renal tubular effects of MMF in the DOCA-salt model in rats (4 weeks without uninephrectomy). Co-treatment with MMF attenuated the rise in blood pressure from day 11 onward resulting in a significantly lower telemetric mean arterial pressure after 4 weeks of treatment (108 +/- 7 vs. 130 +/- 9 mmHg, P < 0.001 by two-way analysis of variance). MMF significantly reduced the number of CD3(+) cells in kidney cortex and inner medulla, but not in outer medulla. In addition, MMF significantly reduced urinary interferon-gamma excretion. Vascular tone was studied ex vivo using wire myographs. An angiotensin II type 2 {AT(2)) receptor antagonist blocked the effects of angiotensin II (Ang II) only in the vehicle group. Conversely, L-NAME significantly increased the Mg II response only in the MMF group. An endothelin A receptor blocker prevented vasoconstriction by endothelin-1 in the MMF but not in the vehicle group. MMF did not reduce the abundances of the kidney sodium transporters NHE3, NKCC2, NCC, or ENaC. Together, our ex vivo results suggest that DOCA-salt induces AT(2) receptor-mediated vasoconstriction. MMF prevents this response and increases nitric oxide availability. These data provide insight in the antihypertensive mechanism of MMF and the role of inflammation in dysregulating vascular tone.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress
    Xia, Huijing
    de Queiroz, Thyago Moreira
    Sriramula, Srinivas
    Feng, Yumei
    Johnson, Tanya
    Mungrue, Imran N.
    Lazartigues, Eric
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2015, 308 (05) : R370 - R378
  • [22] Role of Substance P in Renal Injury During DOCA-Salt Hypertension
    Wang, Youping
    Wang, Donna H.
    ENDOCRINOLOGY, 2012, 153 (12) : 5972 - 5979
  • [23] Effects of L-carnosine on renal sympathetic nerve activity and DOCA-salt hypertension in rats
    Niijima, A
    Okui, T
    Matsumura, Y
    Yamano, T
    Tsuruoka, N
    Kiso, Y
    Nagai, K
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2002, 97 (02): : 99 - 102
  • [24] Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats
    Guimaraes, Priscila S.
    Santiago, Nivia M.
    Xavier, Carlos H.
    Velloso, Elizabeth P. P.
    Fontes, Marco A. P.
    Santos, Robson A. S.
    Campagnole-Santos, Maria Jose
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 303 (03): : H393 - H400
  • [25] Cardiometabolic Effects of DOCA-Salt in Mice Depend on Ambient Temperature
    Grobe, Connie C.
    Reho, John J.
    Brown-Williams, Daeleon
    Ziegler, Alisha A.
    Mathieu, Natalia M.
    Lawton, Samuel B. R.
    Fekete, Eva M.
    Brozoski, Daniel T.
    Wackman, Kelsey K.
    Burnett, Colin M. L.
    Nakagawa, Pablo
    Sigmund, Curt D.
    Segar, Jeffrey L.
    Grobe, Justin L.
    HYPERTENSION, 2023, 80 (09) : 1871 - 1880
  • [26] Evaluation of the coronary angiogenesis during DOCA-salt induced hypertension and its reversal to normal in rat
    Zarei, Mohammad
    Khazaei, Majid
    Zarei, Mohammad M.
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 : 368 - 372
  • [27] Renal Inflammation in DOCA-Salt Hypertension Role of Renal Nerves and Arterial Pressure
    Banek, Christopher T.
    Gauthier, Madeline M.
    Van Helden, Dusty A.
    Fink, Gregory D.
    Osborn, John W.
    HYPERTENSION, 2019, 73 (05) : 1079 - 1086
  • [28] Collecting duct-specific knockout of sphingosine-1-phosphate receptor 1 aggravates DOCA-salt hypertension in mice
    Hu, Gaizun
    Zhu, Qing
    Wang, Weili
    Xie, Dengpiao
    Chen, Chaoling
    Li, Pin-Lan
    Ritter, Joseph K.
    Li, Ningjun
    JOURNAL OF HYPERTENSION, 2021, 39 (08) : 1559 - 1566
  • [29] Combined effects of AT1 and ETA receptor antagonists, candesartan, and A-127722 in DOCA-salt hypertensive rats
    Pollock, DM
    Derebail, VK
    Yamamoto, T
    Pollock, JS
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 2000, 34 (05): : 337 - 342
  • [30] ROS Suppression by Egg White Hydrolysate in DOCA-Salt Rats-An Alternative Tool against Vascular Dysfunction in Severe Hypertension
    Abreu, Edina da Luz
    Moro, Camila Rodrigues
    Husein Kanaan, Samia Hassan
    de Paula, Ricardo Bernardino
    Herrera, Camila Teixeira
    Dorneles Costa, Pedro Henrique
    Pecanha, Franck Maciel
    Vassallo, Dalton Valentim
    Rossoni, Luciana Venturini
    Miguel-Castro, Marta
    Wiggers, Giulia Alessandra
    ANTIOXIDANTS, 2022, 11 (09)